Search company, investor...


Seed | Alive

About Sunrise

Sunrise is a company focused on sleep science, specifically in the medical sector. The company offers a certified medical device for diagnosing sleep apnea, providing a simple and efficient home-based solution for sleep testing. Sunrise primarily serves individuals, healthcare practitioners, and businesses. It is based in Loyers, Belgium.

Headquarters Location

Chaussée de Marche, 569

Loyers, 5101,




Expert Collections containing Sunrise

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sunrise is included in 1 Expert Collection, including Smart Home & Consumer Electronics.


Smart Home & Consumer Electronics

1,234 items

This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.

Latest Sunrise News

Sunrise Attracts $6M Investment from Amazon’s Alexa Fund and UI-Investissement

Nov 16, 2023

Belgium-based Sunrise, developer of a chin patch home sleep test , has welcomed an additional aggregate investment of $6 million from Amazon’s Alexa Fund and French healthcare investor UI-Investissement, for a total of $24 million raised this year. This new funding enables Sunrise to expand its reach further, making sleep diagnostics more accessible and personalized, according to Sunrise CEO Laurent Martinot. “This funding round is a vote of confidence, not just in Sunrise, but in the universal need for better sleep health solutions,” says Martinot in a release. Sunrise has secured US Food and Drug Administration clearance in the United States, a renewed CE certification in Europe, and the 2022 SleepTech Award from the National Sleep Foundation. Sunrise’s approach to sleep monitoring centers around mandibular jaw movements. Much like the diaphragm supports breathing during sleep, the jaw also plays a key role. By focusing on these jaw movements, Sunrise delivers a high-precision tool for sleep diagnosis. And all it takes is an eight-gram sensor placed on the chin. Sunrise also measures respiratory effort. This allows for the distinction between central and obstructive sleep apnea. It also offers new metrics like respiratory effort burden, linked to fatigue, type 2 diabetes, and hypertension. “Sleep disorders are a global concern, and we’re proud to be an investor in Sunrise and support their innovative approach to aid in the diagnosis of sleep-related breathing disorders,” says Paul Bernard, director of the Alexa Fund, in a release. “Their technology, designed for multi-night testing that leverages key sleep metrics, has the potential to redefine sleep apnea diagnosis and care for millions of people suffering from sleep disorders worldwide.” Share:

Sunrise Frequently Asked Questions (FAQ)

  • Where is Sunrise's headquarters?

    Sunrise's headquarters is located at Chaussée de Marche, 569, Loyers.

  • What is Sunrise's latest funding round?

    Sunrise's latest funding round is Seed.

  • Who are the investors of Sunrise?

    Investors of Sunrise include European Innovation Council and EIC Accelerator.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.